
Biomednewsbreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances Rtnova Platform With IL15 Superagonist ...
(MENAFN- Investor Brand Network) Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its systemic antitumor virotherapy platform, RTNova. Preclinical data presented at …